Patent Assignment
Reel/Frame 018903/0447
Merger
Recorded: 2007-02-19
Pages: 11
Assignor
ILEX PRODUCTS, INC.
Executed: 2005-06-30
Assignee
GENZYME CORPORATION
153 SECOND AVENUE, WALTHAM, MASSACHUSETTS, 02451
Covered Property
(1)
MUC1 extracellular domain and cancer treatment compositions and methods derived therefrom
Application:
09/951,938 →
Publication:
US 2005/0053606
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 4, 2002
From: KUFE, DONALD W.; OHNO, TSUNEYA
To: ILEX ONCOLOGY, INC.; DANA FARBER CANCER INSTITUTTE
Reel/Frame 012600/0627 →
Assignment of Assignor's Interest
Sep 9, 2003
From: ILEX ONCOLOGY, INC.
To: ILEX PRODUCTS, INC.
Reel/Frame 013951/0904 →
Confirmatory License
Aug 8, 2016
From: DANA-FARBER CANCER INST
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039601/0423 →
Confirmatory License
Sep 21, 2016
From: DANA-FARBER CANCER INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR
Reel/Frame 039810/0423 →